Cytohesin-2 is a member of the guanine nucleotide exchange factors for ADP ribosylation factor 1 (Arf1) and Arf6, which are small GTPases that regulate membrane traffic and actin dynamics. In this study, we first demonstrated that cytohesin-2 localized to the plasma membrane and vesicles in various subcellular compartment in hippocampal neurons by immunoelectron microscopy. Next, to understand the molecular network of cytohesin-2 in neurons, we conducted yeast twohybrid screening of brain cDNA libraries using cytohesin-2 as bait and isolated pallidin, a component of the biogenesis of lysosome-related organelles complex 1 (BLOC-1) involved in endosomal trafficking. Pallidin interacted specifically with cytohesin-2 among cytohesin family members. Glutathione S-transferase pull-down and immunoprecipitation assays further confirmed the formation of a protein complex between cytohesin-2 and pallidin. Immunofluorescence demonstrated that cytohesin-2 and pallidin partially colocalized in various subsets of endosomes immunopositive for EEA1, syntaxin 12, and LAMP2 in hippocampal neurons. Knockdown of pallidin or cytohesin-2 reduced cytoplasmic EEA1-positive early endosomes. Furthermore, knockdown of pallidin increased the total dendritic length of cultured hippocampal neurons, which was rescued by co-expression of wild-type pallidin but not a mutant lacking the ability to interact with cytohesin-2. In contrast, knockdown of cytohesin-2 had the opposite effect on total dendritic length. The present results suggested that the interaction between pallidin and cytohesin-2 may participate in various neuronal functions such as endosomal trafficking and dendritic formation in hippocampal neurons.
endosomes. In addition to membrane trafficking, endosomes serve as a signaling platform where multi-protein signaling complexes are assembled (Hirling 2009 ). In neurons, endosomal trafficking is essential not only for the maintenance of cellular homeostasis but also for specific functions including the establishment of neuronal polarity, migration, neurite formation, secretion, and recycling of synaptic vesicles, and synaptic plasticity (Kelly et al. 2011; Solecki 2012; Yap and Winckler 2012; Di Fiore and von Zastrow 2014; Jahne et al. 2015) . Furthermore, it has recently emerged as a common biological process affected by neurodevelopmental disorders such as schizophrenia, autism spectrum disorder, and intellectual disability (Ryder and Faundez 2009; Mullin et al. 2013) , and neurodegenerative diseases such as lysosomal storage diseases, Parkinson's disease, and Alzheimer's disease (Schreij et al. 2016) .
ADP ribosylation factors (Arfs) belonging to the Ras superfamily are critical small GTPases that regulate membrane trafficking along secretory and endosomal pathways. The mammalian Arf family is composed of six members, which are grouped into three classes on the basis of structural similarity: class I (Arf1, Arf2, and Arf3 except human Arf2 being lost as a pseudogene), class II (Arf4 and Arf5), and class III (Arf6) (D'Souza-Schorey and Chavrier 2006; Gillingham and Munro 2007; Donaldson and Jackson 2011) . Previous studies have mostly focused on the roles of Arf1 and Arf6. Arf1 localizes primarily to the Golgi complex and controls vesicular transport between the endoplasmic reticulum and the Golgi along the secretory pathway. On the other hand, Arf6 localizes to the plasma membrane and endosomes, and controls membrane trafficking such as exocytosis and endocytosis, as well as the dynamics of the actin cytoskeleton beneath the plasma membrane. Similar to other small GTPases, Arfs cycle as a molecular switch between two states, namely GDP-bound inactive and GTP-bound active states. Guanine nucleotide exchange factors (GEFs) catalyze the conversion of Arf-GDP to Arf-GTP and trigger the conformational change in the Arf, thereby leading to the recruitment and activation of specific downstream effectors such as coat complexes, lipid modifying enzymes, scaffold proteins, and cytoskeletal regulators. On the other hand, GTPase-activating proteins terminate the activation of Arf by catalyzing the hydrolysis of GTP to GDP. The existence of multiple GEFs and GTPase-activating proteins leads to the idea that the cellular expression, subcellular localization, and protein-protein interactions of these regulatory proteins are the major determinants not only for the timing and location of Arf activation but also for the specificity of downstream cascades that each Arf activates (Gillingham and Munro 2007) . Therefore, information on their subcellular localization and molecular network is crucial to understand the physiological functions of Arfs.
The cytohesin family of Arf-GEFs is composed of four homologous members with a low molecular weight of 45-50 kDa: cytohesin-1 (also known as Arf nucleotide-binding site opener 2 [ARNO2]) (Kolanus et al. 1996) , cytohesin-2 (ARNO) (Chardin et al. 1996) , cytohesin-3 (ARNO3 or general receptor for phosphoinositides 1) (Klarlund et al. 1997; Franco et al. 1998) , and cytohesin-4 (Ogasawara et al. 2000) . They share a common domain structure consisting of an N-terminal coiled coil domain, a central guanine nucleotide catalytic domain (Sec7 domain), and a C-terminal pleckstrin homology (PH) domain. Although the physiological substrates of cytohesins are still a subject of debate, all cytohesins can activate more than one Arf isoform at least in vitro. Cytohesin-1, -2, and -3 can activate Arf1 and Arf6 (Frank et al. 1998; Langille et al. 1999) , whereas cytohesin-4 can activate Arf1 and Arf5 but not Arf6 (Ogasawara et al. 2000) . In the brain, cytohesin-1, -2, and -3 exhibited distinct but overlapping mRNA expression profiles in neuronal populations such as the cerebral cortex and hippocampus (Suzuki et al. 2002) . In relation to their neuronal functions, cytohesin-2, the best characterized cytohesin member, was shown to mediate diverse neuronal functions including the formation of axons and dendrites in cultured hippocampal neurons (HernandezDeviez et al. 2002 and Hernandez-Deviez et al. 2004) , valproic acid-induced neurite outgrowth in N1E-115 neuroblastoma cells (Yamauchi et al. 2009) , and the trafficking of group I metabotropic glutamate receptors (mGluRs) to the postsynaptic membrane (Kitano et al. 2002) . However, the lack of information on the subcellular localization of cytohesin-2 in neurons hampers our further understanding of its neuronal functions in vivo. An increasing number of cytohesininteracting proteins have been identified recently (Table 1) , supporting the idea that subcellular targeting and functioning of cytohesin depend on its specific protein-protein interactions. However, because most of these partner proteins identified so far seem to exhibit promiscuous abilities to interact with cytohesin members, the mechanisms of how individual cytohesins can exert isoform-specific functions remain unknown.
Pallidin was originally identified by positional cloning of a gene mutated in the pallid mouse, a mouse model for Hermansky-Pudlack syndrome, a rare genetic disorder that causes oculocutaneous albinism, bleeding, and lysosomal ceroid storage (Huang et al. 1999) . Pallidin forms a multiprotein complex called the biogenesis of lysosome-related organelles complex-1 (BLOC-1) with muted (Falcon-Perez et al. 2002) , cappuccino (Gwynn et al. 2000; Ciciotte et al. 2003) , dysbindin (Li et al. 2003) , snapin (Starcevic and Dell'Angelica 2004) , blos-1, blos-2, and blos-3 (Gwynn et al. 2004; Starcevic and Dell'Angelica 2004) . Based on the interaction of pallidin with syntaxin 12, an endosomal target membrane-associated soluble N-ethylmaleimide-sensitive factor attachment protein receptor (tSNARE), pallidin is suggested to be involved in endosomal trafficking (Huang et al. 1999) . In non-neuronal cell lines, BLOC-1 indeed regulates cargo-specific sorting from early endosomes to PH + polybasic C of cytohesin-2
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Regulation of the adhesion between aLb2 and ICAM-1 and cell spreading in Jurkat cells Kolanus et al. (1996) lysosome-related organelles such as melanosomes in melanocytes (Setty et al. 2007) , and from recycling endosomes to the primary cilium (Monis et al. 2017) . Furthermore, the identification of dysbindin as a susceptible gene for schizophrenia has gained much attention on the neuronal roles of BLOC-1 (Straub et al. 2002) . Consistently, mice deficient in dysbindin or pallidin exhibit impaired working memory and social interactions, which are consistent with cognitive functions impaired in schizophrenia patients (Takao et al. 2008; Bhardwaj et al. 2009; Cox et al. 2009; Jentsch et al. 2009; Karlsgodt et al. 2011; Glen et al. 2014; Spiegel et al. 2015) . In neurons, BLOC-1 is implicated in the biogenesis and release of synaptic vesicles in presynaptic terminals (Newell-Litwa et al. 2009; Di Giovanni and Sheng 2015; Chen et al., 2017) . In addition, neurons from pallid mutant mice show impaired neurite outgrowth (Ghiani et al. 2010) , suggesting the multifaceted roles of pallidin in mature and developing neurons. However, our understanding of the neuronal functions of pallidin is still incomplete. In this study, we first demonstrated the detailed cellular and subcellular localization of cytohesin-2 in the mouse brain by immunohistochemistry using an isoform-specific antibody. By yeast two-hybrid screening, we identified pallidin as a novel interacting protein specific for cytohesin-2 among the cytohesin family. In cultured hippocampal neurons, cytohesin-2 and pallidin were found to colocalize in subsets of endosomes, and knockdown of either cytohesin-2 or pallidin similarly decreased cytoplasmic early endosome antigen 1 (EEA1)-positive early endosomes. Furthermore, knockdown of pallidin enhanced dendritic growth, which could not be rescued by supplementation of a pallidin mutant lacking the ability to interact with cytohesin-2. Together, the present results provide the first evidence for a functional relationship between cytohesin-2 and pallidin in neurons.
Materials and methods

Animals
Three male C57BL/6 mice in the 10th postnatal week (CLEA Japan, Tokyo, Japan, RRID: IMSR_JAX:000664) were used for immunoperoxidase staining, three for immunofluorescent staining, three for immunoelectron microscopic analysis, three for immunoblotting, ten pregnant ICR mice (CLEA Japan, RRID: MGI:5653323) for hippocampal primary culture, and two female guinea pigs (250-350 g, Hartley, Japan Laboratory Animals, Tokyo, Japan) for immunization. Adult mice (5 per cage), pregnant mice (1 per cage), and guinea pigs (2 per cage) were housed and .
DNA constructs
The cDNAs for full-length cytohesins and pallidin, and their truncated mutants shown in Fig. 2 were amplified from a mouse brain cDNA library by PCR using the combinations of primers shown in for protein expression in bacteria. Pallidin mutants in which the first coiled coil domain (DCC1) was deleted or leucine residues at 71, 74, and/or 85 were replaced with proline, and shRNA-resistant wild-type pallidin were made using a PrimeSTAR mutagenesis basal kit (R046A, Takara Bio, Tokyo, Japan) with the primers shown in Table 2 in accordance with the manufacturers' protocols. For knockdown experiments, modified mU6pro vectors, which can simultaneously express shRNA regulated by a U6 promoter and enhanced green fluorescent protein (EGFP) or mCherry regulated by a cytomegalovirus promoter, were used as described previously (Yazaki et al. 2014) . Target sequences of shRNAs for pallidin, mismatched pallidin (control), cytohesin-2, mismatched cytohesin-2 (control), and firefly luciferase were 5 0 -TCACACAGAACCAAGTTGTGT-3 0 ,
0 , and 5 0 -GC GCAGCTATGAGTTCTT-3 0 , respectively. Small letters indicate the nucleotides mismatched between targets and control shRNAs. Plasmids used for neuronal transfection were purified using an EndoFree plasmid kit (12362, Qiagen, Hilden, Germany).
Antibodies
The antibodies used in this study are summarized in Table 3 . Fulllength mouse cytohesin-2 (GenBank Accession No. AF079971) was transformed with pGEX-4T-2-cytohesin-2 or pMAL-2c-cytohesin-2, respectively, in the presence of 0.3 mM isopropyl-b-D-thiogalactopyranoside at 25°C overnight. The GST-and MBP-cytohesin-2 fusion proteins were purified using glutathione-Sepharose 4B (71075605, GE Healthcare) and amylose-resin (E8021L, New England Biolabs), respectively, and used for the immunization of guinea pigs and the affinity purification of antibodies, respectively. The GST-cytohesin-2 fusion protein was emulsified with Freund's adjuvant and injected subcutaneously into guinea pigs five times at 2-week intervals. Specific antibodies were affinity-purified from antisera using MBP-cytohesin-2 conjugated to CNBr-activated Sepharose 4B beads (17043001, GE Healthcare). Because the resultant antibody still cross-reacted slightly with other cytohesin members, they were further affinity-purified using the C-terminal region (amino acids 387-400) of mouse cytohesin-2, the most divergent region among the cytohesin members, conjugated to CNBr-activated Sepharose 4B (17043001, GE Healthcare). Other antibodies used for immunoblotting and immunofluorescence were as follows: rabbit anti-pallidin IgG (10891-2-AP, ProteinTech, Chicago, IL, USA, RRID: AB_2164174); rabbit anti-EEA1 IgG ; mouse anti-EEA1 IgG (610457, BD biosciences, Franklin Lakes, NJ, USA, RRID: AB_397830); rabbit and guinea pig anti-syntaxin 12 IgG (Hara et al. 2013) ; anti-LAMP2 IgG (sc-8100, Santa Cruz, Dallas, TX, RRID: AB_2134754); guinea pig anti-MAP-2 IgG (MAP2-Go-Af860, Frontier Institute, Ishikari, Japan, RRID: AB_2571557); mouse anti-CC-1 IgG (Ab16794, Abcam, Cambridge, UK RRID: AB_443473); goat anti-GFAP (GFAP-Go-Af1000, Frontier institute, RRID: AB_2571708); goat anti-Iba1 IgG (Ab5076, Abcam, RRID: AB_2224402); mouse anti-FLAG-tag IgG (F1804, Sigma-Aldrich, St. Louis, MO, RRID: AB_262044); rabbit anti-human influenza hemagglutinin (HA)-tag IgG (561-5, Medical & Biological Laboratories (MBL), Nagoya, Japan, RRID: AB_591844); guinea pig anti-EGFP IgG (Sakagami (Hara et al. 2013) ; mouse anti-a-tubulin IgG (T9026, Sigma-Aldrich, RRID: AB_477593); mouse anti-GAPDH IgG (CB1001, Merck, Darmstadt, Germany, RRID: AB_2107426).
Immunostaining for brain sections
Under deep anesthesia with sodium pentobarbital (100 mg/kg of body weight, i.p.), mice were transcardially perfused with 4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB) and 4% paraformaldehyde/0.1% glutaraldehyde in 0.1 M PB for immunohistochemistry at light and electron microscopic levels, respectively. Brains were post-fixed with the same fixative for 3 h. For immunoperoxidase staining, brains were embedded in paraffin and sections were made at a thickness of 5 lm using a sliding microtome (REM-710, Yamato, Asaka, Japan). Sections were treated with 5% donkey serum in phosphate-bufferd saline (PBS), followed by incubation with primary antibody against cytohesin-2 (1.0 lg/mL, guinea pig) overnight, with biotinylated secondary antibody (1:200, BA-7000, Vector Laboratories, Burlingame, CA, USA) for 2 h, and then with the avidin-biotin-peroxidase complex (PK-6100, DAKO, Carpinteria, CA, USA) for 1 h. The immunoreaction was visualized in substrate solution containing 3,3 0 -diaminobenzidine and hydrogen peroxide (GV825, DAKO). For immunofluorescence, floating sections were made at a thickness of 50 lm on a vibrating microtome (VT1000, Leica, Nussloch, Germany). Sections were permeabilized with 0.3% Triton X-100 in PBS for 30 min, incubated with 5% donkey serum in PBS for 30 min, and with anti-cytohesin-2 IgG (1.0 lg/mL, guinea pig) overnight. For double immunofluorescent staining, floating sections were incubated with the following combinations of primary antibodies: anti-cytohesin-2 IgG (1.0 lg/mL, guinea pig) and antibodies against EEA1 (0.5 lg/mL, mouse), syntaxin 12 (0.5 lg/ mL, rabbit), LAMP2 (0.5 lg/mL, goat), CC-1 (1.0 lg/mL, mouse), GFAP (0.5 lg/mL, goat), or Iba1 (1.0 lg/mL,goat). The immunoreaction was visualized using species-specific secondary antibodies conjugated with Alexa488 or Alexa594 (0.5 lg/mL for each; A-21206, A-21202, A-21207, A-21203, Invitrogen; 705-545-147, 705-585-147, 706-545-148, 706-585-148 , Jackson ImmunoResearch, West Grove, PA, USA). Sections were counter-stained with 4 0 ,6-diamidino-2-phenylindole (DAPI, 10236276001, Roche, Mannheim, Germany) and examined using a confocal laser microscope (LSM 710, Carl Zeiss, Oberkochen, Germany). For pre-embedding immunoelectron microscopy, free-floating sections were incubated with guinea pig anti-cytohesin-2 IgG overnight and subsequently with nanogold-conjugated anti-guinea pig IgG (1 : 100, Nanoprobes, Yaphank, NY, USA) at 25°C for 2 h. Immunogold particles were intensified using a HQ Silver Enhancement kit (Nanoprobes). The sections were post-fixed with 2% osmium tetroxide, dehydrated, and embedded in epoxy resin. Ultrathin sections were made at a thickness of 70 nm using an ultra-microtome (Ultracut, Leica), contrasted with 2% uranyl acetate, and examined using an electron microscope (H-7650, Hitachi, Tokyo, Japan).
Yeast two-hybrid screening
The yeast two-hybrid method has been described in detail previously (Sakagami et al. 2007) . MaV203 yeast cells (11445012, Invitrogen) were co-transformed with full-length cytohesin-2 in a pDBLeu bait vector and mouse or rat brain cDNA libraries in a pPC86 prey vector. Approximately 4 9 10 6 transformants were subjected to auxotrophic selection on synthetic dropout medium without histidine, tryptophan, or leucine in the presence of 10 mM 3-amino-1,2,4-triazole. Positive colonies were further selected by b-galactosidase activity and prototrophy for uracil in accordance with the manufacturer's protocol (PQ10001-01, ProQuest Two-Hybrid system, Invitrogen). Candidate prey vectors were isolated and sequenced.
HeLa cell and transfection
HeLa cells (TKG0331, RRID: CVCL_0030) obtained from the Cell Resource Center for Biomedical Research (Tohoku University, Japan) were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum in 5% CO 2 at 37°C. This HeLa cell line has not been listed as a misidentified cell line by the International Cell Line Authentication Committee (ICLAC). This cell line has not been authenticated by the short tandem repeat analysis. Cells were plated onto 35-mm dishes at a density of 1.0 9 10 6 per plate and transfected with expression vectors using Lipofectamine 2000 (11668019, ThermoFisher, Waltham, MA, USA). One day after transfection, cells were harvested and subjected to immunoblotting, GST pull-down assay, or immunoprecipitation analysis.
GST pull-down assay
The bacterially expressed GST fusion protein of full-length pallidin was conjugated to glutathione-Sepharose 4B (71075605, GE Healthcare) in PBS containing 0.5% Nonidet P-40 and a cocktail of proteinase inhibitors (11697498001, Roche). HeLa cells were transiently transfected with pEGFP-C-cytohesin-1 or pEGFP-Ccytohesin-2 and harvested with a buffer consisting of 50 mM TrisHCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, and protease inhibitors (11697498001, Roche). Equal amounts (15 lg) of GSTpallidin immobilized on glutathione-Sepharose beads were incubated with HeLa cell extracts at 4°C overnight. The precipitates and lysates were immunoblotted with an anti-EGFP antibody (0.2 lg/mL, guinea pig).
Immunoprecipitation
HeLa cells were transfected with pCMV-HA-pallidin and pCAGGS-FLAG-cytohesin-1 or cytohesin-2 using Lipofectamine 2000 (11668019, ThermoFisher). The cells were harvested with a buffer consisting of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, and a cocktail of protease inhibitors (11697498001, Roche). The lysates were immunoprecipitated with anti-HA IgG-conjugated agarose beads (561-8, MBL). The immunoprecipitates and lysates were subjected to immunoblotting with anti-FLAG (0.1 lg/mL) and anti-HA (0.2 lg/mL) antibodies. For immunoprecipitation of the endogenous protein complex, whole mouse brains were homogenized in a buffer consisting of 10 mM Tris-HCl (pH 7.4), 320 mM sucrose, 10 mM EDTA, 10 mM EGTA, and protease inhibitors. After the nuclear fraction was removed, the samples (200 lg) were dialyzed against binding buffer consisting of 50 mM Tris-HCl (pH 7.4) and 1% Triton X-100 for 1 h at 4°C and incubated overnight at 4°C with the protein G-conjugated Dynabeads (DB10004, ThermoFisher) coupled with 6 lg of anti-pallidin, anti-cytohesin-2, or normal rabbit IgG. The immunoprecipitates were washed extensively with binding buffer. The immunoprecipitates and lysates were subjected to the immunoblotting with antibodies against pallidin (0.5 lg/mL) and cytohesin-2 (1.0 lg/mL).
Immunostaining for cultured hippocampal neurons
Hippocampal neuronal culture was prepared as described previously (Beaudoin et al. 2012 ) with minor modifications. Hippocampi were dissected from neonatal mice, dissociated by trypsin treatment, and triturated through a Pasteur pipette. Hippocampal cells were plated onto 35-mm dishes containing a thin plastic coverslip (MS-92302Z, Cell Desk LF2, Sumitomo Bakelite, Tokyo, Japan) coated with poly-D-lysine at a density of 1.2 9 10 6 cells per dish. Neurons were fixed at 5 days in vitro (DIV5) with 4% paraformaldehyde in 0.1 M PB (pH 7.2) for 15 min, and permeabilized with 0.3% Triton X-100 in PBS for 30 min. After blocking with 5% normal donkey serum in PBS for 30 min, the dishes were incubated with the following combinations of primary antibodies: anti-pallidin (0.5 lg/mL, rabbit), anticytohesin-2 (1.0 lg/mL, guinea pig), and anti-EEA1 (0.5 lg/mL, mouse); anti-pallidin (0.5 lg/mL, rabbit) and anti-EGFP (0.2 lg/ mL, guinea pig); anti-EEA1 (0.5 lg/mL, rabbit) and anti-EGFP (0.5 lg/mL, guinea pig); anti-cytohesin-2 (1.0 lg/mL, guinea pig) and anti-mCherry (0.2 lg/mL, rabbit); and anti-EGFP (0.2 lg/mL, guinea pig) and anti-MAP2 (0.5 lg/mL, goat). The immunoreaction was visualized using Alexa488-conjugated anti-guinea pig IgG (0.5 lg/mL, 706-545-148, Jackson ImmunoResearch), Alexa594-conjugated anti-rabbit or goat IgG, and Alexa647-conjugated antimouse IgG antibodies (0.5 lg/mL for each, A21207, A11058, A31571, ThermoFisher). Coverslips were counter-stained with DAPI (10236276001, Roche) and examined using a confocal laser microscope (LSM 710, Carl Zeiss). The colocalization coefficient, which represented the proportion of pixels colabeled with two fluorophores amongst all pixels labeled with a fluorophore, were measured using ZEN software (Manders' split coefficients, Carl Zeiss). Colocalization coefficient data were obtained from more than 20 healthy neurons in each condition. Data were representative of three independent experiments.
Quantification of EEA1-positive endosomes in cultured hippocampal neurons Cultured hippocampal neurons were transfected with shRNA vectors (1 lg) using Lipofectamine 2000 (ThermoFisher) at DIV2, fixed at DIV5 with 4% paraformaldehyde/0.1 M PB, and subjected to immunofluorescent staining with antibodies against EEA1 and EGFP. The density of EEA1-positive endosomes in neurons was calculated from more than 20 healthy transfected neurons in each condition by measuring the number of EEA1-positive puncta in the given area of cell bodies and dendrites using ImageJ software (NIH). Data were representative of three independent experiments.
Transferrin incorporation assay
Cultured hippocampal neurons were transfected with pallidin or control shRNA vectors using Lipofectamine 2000 (ThermoFisher) at DIV7. Two days after transfection, neurons were incubated with medium containing 25 lg/mL Alexa594-conjugated transferrin (T13343, ThermoFisher) for 10 min at 37°C. The neurons were then rinsed with stripping buffer containing 154 mM NaCl/0.5% acetic acid for 30 sec, fixed with 4% paraformaldehyde/0.1 M PB for 15 min, and immunostained with anti-EGFP antibody. Fluorescence images were acquired using a confocal laser scanning microscope (LSM 710, Carl Zeiss). The fluorescence intensities of transferrin in the cell bodies of transfected neurons were measured from more than 20 healthy transfected neurons in each condition using ImageJ software (NIH). Data were representative of three independent experiments.
Hippocampal lysates and immunoblotting analysis
Hippocampi of ICR mice at various developmental stages were homogenized in a buffer consisting of 125 mM Tris-HCl (pH 7.5), 4% sodium dodecyl sulfate, 10% glycerol, 10% b-mercaptoethanol, and protease inhibitors (11697498001, Roche), and boiled for 5 min. Protein samples (10 lg for each lane) and lysates of HeLa cells were electrophoretically separated on a 10% sodium dodecyl sulfate-polyacrylamide gel and transferred onto polyvinylidene fluoride membranes (10485289, GE Healthcare). After blocking with 5% non-fat dry milk in PBS containing 0.1% Tween 20, membranes were incubated with anti-cytohesin-2 or anti-pallidin IgG diluted in Tris-buffered saline (pH 7.5) containing 0.5% bovine serum albumin and 0.1% Tween 20 overnight and then with a peroxidase-linked secondary antibody (1 : 5000, NA934-1ML, GE Healthcare) for 1 h. The immunoreaction was visualized using a chemiluminescent detection kit (32132, Western Blotting Substrate Plus, Pierce, Rockford, IL, USA) and an image analyzer (ImageQuant LAS4000, GE Healthcare). The same membranes were subsequently reprobed with anti-a-tubulin IgG as an internal loading control. The optical density of each immunoreactive band was quantified from three independent blots using ImageJ software (NIH).
Quantification of length and branching of axons and dendrites Cultured hippocampal neurons were transfected with shRNA (1 lg) or shRNA and rescue vectors (1 lg for each) using Lipofectamine 2000 (ThermoFisher) at DIV2, fixed at DIV5 with 4% paraformaldehyde/0.1 M PB, and subjected to immunostaining with antibodies against EGFP or mCherry and MAP2 to visualize transfected neurons and dendrites, respectively. Nuclei were also counter-stained with DAPI to assess the cell viability. Immunofluorescence images of neuronal morphology were taken using a confocal laser scanning microscope (LSM 710, Carl Zeiss). The length and tip numbers of axons and dendrites were examined using ImageJ software (NIH).
Experimental design and statistical analysis
No sample size calculation and no blinding were performed in this study. The study was not pre-registered. Prior to the statistical comparisons, assessment of the normality of all data was carried out by Kolmogorov-Smirnov and Shapiro-Wilk tests. Students' t-test was used for comparisons between the two evaluations within each group. Statistical significance was set at p < 0.05. For multiple comparisons, data were processed by the one-factor analysis of variance (ANOVA), followed by Fisher's protected least significant difference (PLSD) post hoc test. Data are presented as mean AE standard deviation (SD, Fig. 1 , 3-5, 
Results
Cytohesin-2 is associated with various membrane structures in neurons We began our study with an immunohistochemical examination of the cellular and subcellular localization of cytohesin-2 in the adult mouse brain using a novel anticytohesin-2 antibody. The anti-cytohesin-2 antibody detected a single immunoreactive band of 43 kDa, which was consistent with the predicted molecular weight (46.5 kDa) of cytohesin-2, from immunoblotting of lysates of mouse brain (Fig. 1a) . Furthermore, the antibody detected EGFPcytohesin-2, which corresponded to the upper band of the two immunoreactive bands that anti-EGFP antibody detected in the lysate of EGFP-cytohesin-2-transfected HeLa cells, whereas it did not cross-react with other closely related cytohesins (EGFP-cytohesins-1, -3, or -4) or EGFP alone over-expressed in HeLa cells (Fig. 1a) . The lower EGFPimmunoreactive band was likely to be a degradative product of EGFP-cytohesin-2, because two immunoreactive bands were detectable by the anti-EGFP antibody in all lysates of transfected HeLa cells after long exposure. These results supported the specificity of the anti-cytohesin-2 antibody. In the adult mouse brain, immunoperoxidase labeling for cytohesin-2 was widely distributed in brain regions including the olfactory bulb, hippocampal formation, cerebral cortex, caudate putamen, thalamus, cerebellar cortex, medulla oblongata, and spinal cord (Fig. 1b) . This immunolabeling was completely attenuated by pre-absorption of the primary antibody with the antigen (Fig. 1c) or in brains of cytohesin-2 knockout mice (data not shown), suggesting the specific immunolabeling of endogenous cytohesin-2 with this antibody. In the hippocampal formation, where previous functional analyses on the cytohesin-Arf pathway had been performed intensively (Hernandez-Deviez et al. 2002 , marked immunolabeling for cytohesin-2 was detected throughout cell layers and dendritic fields of the dentate gyrus and hippocampal CA1-3 regions (Fig. 1d) . At high magnification, the CA1 region showed immunofluorescent signals for cytohesin-2 appeared as numerous dense, fine puncta beneath the plasma membrane and throughout the cytoplasm of cell bodies and proximal dendritic processes (Fig. 1e) . Double immunofluorescence revealed that cytohesin-2-immunoreactive puncta were partially overlapped or associated with EEA1 ( Fig. 1f-h ), syntaxin 12 (Fig. 1i-k) , and LAMP2 (Fig. 1l-n) , markers for early endosomes, early and recycling endosomes, and late endosomes and lysosomes, respectively.
To further examine the subcellular localization of cytohesin-2 at the ultrastructural level, we performed preembedding immunoelectron microscopy of the hippocampal CA1 region. Silver-intensified immunoreactive metal particles were widely distributed in various subcellular compartments including cell bodies, dendritic shafts, dendritic spines, axon shafts, and axon presynaptic terminals above the background level ( Fig. 1o and p) . In the dendritic shaft, immunoreactive particles for cytohesin-2 were largely associated with the plasma membrane, and intracellular vesicular membrane structures, which presumably corresponded to endosomes (Fig. 1o ). They were also deposited on the outer limiting membrane of multivesicular bodies (Fig. 1o) . In the dendritic spine, immunoreactive particles were deposited on the plasma membrane, frequently at the lateral margin of the postsynaptic density, and on vesicular membrane structures (Fig. 1p) . No immunolabeling was observed on mitochondria. These results suggested the association of cytohesin-2 with the plasma membrane and subsets of endosomes in various subcellular compartments in neurons. A further quantitative analysis revealed that the density of immunoreactive particles was high in dendritic spines, dendritic shafts, and cell bodies, moderate in axon presynaptic terminals, and low in axon shafts among neuronal subcellular compartments (Fig. 1q) . In addition to neuronal labeling, double immunofluorescence revealed that the immunolabeling for cytohesin-2 was also detected in oligodendrocytes, astrocytes, and microglia, which were identified by double immunolabeling with CC-1, GFAP, and Iba1, respectively ( Supplementary Fig. 1 ).
Pallidin is a novel interacting protein for cytohesin-2 Previous identification of cytohesin-interacting proteins (Table 1) suggests that subcellular targeting and functioning of cytohesin depend on the interaction with specific interacting proteins. To further isolate novel interacting proteins for cytohesin-2 in the brain, we performed yeast two-hybrid screening of rat and mouse brain cDNA libraries using cytohesin-2 as bait, and isolated cDNA clones encoding pallidin, a component of BLOC-1 that is involved in endosomal-lysosomal trafficking (Falcon-Perez et al. 2002) , from both cDNA libraries. The cDNA for mouse pallidin isolated from positive yeast (clone #2) included an entire coding region and 26 nucleotides upstream of its translation initiation site (Fig. 2a) , which were supposed to be properly translated in frame as a fusion protein of GAL4 DNA-binding domain in the yeast. In addition to pallidin, known cytohesin-interacting proteins, FERM domain-containing protein 4A (FRMD4A) (Ikenouchi and Umeda 2010) , connector enhancer of kinase suppressor of Ras 2 (CNK2) (Lim et al. 2014) , and CNK3/ interaction protein for cytohesin exchange factors 1 (IPCEF1) (Venkateswarlu 2003) , were also isolated, suggesting the validity of the present screening.
Pallidin is a 172-amino acid protein containing two coiled coil domains in the central and C-terminal regions, respectively (Fig. 2a) . To determine the region responsible for the interaction of pallidin with cytohesin-2, we co-expressed cytohesin-2 and various pallidin deletion mutants as fusion proteins of GAL4 DNA-binding domain and activation domain, respectively, in yeast. The interactions between cytohesin-2 and the pallidin mutants were evaluated using bgalactosidase activity and the ability to grow on medium lacking histidine, uracil, leucine, and tryptophan. As shown in Fig. 2a , deletion of either the N-terminal 30 amino acids (pallidin [31-172]) or C-terminal 15 amino acids of pallidin (pallidin ) retained the interaction with cytohesin-2 in yeast, whereas further deletion of 10 amino acids at either side (pallidin or [1-147]) completely abolished the interaction. These results suggested that amino acids 31-40 and 148-157 are critical for the interaction or that the structural integrity of pallidin including 31-157 is important for the interaction. The coiled coil domain is known to function as a versatile protein module for protein-protein interactions (Lupas and Gruber 2005; Watkins et al. 2015) . Because the region corresponding to amino acids 31-157 contains the entire first coiled coil domain (CC1), we examined the importance of CC1 for the interaction of pallidin with cytohesin-2. The pallidin mutant lacking the CC1, corresponding to amino acids 68-88 (pallidinDCC1), was found to abolish the ability to interact with cytohesin-2. Furthermore, the substitution of leucine to proline at amino acids 71, 74, or 85 in CC1, which are evolutionally conserved in pallidin orthologs among Drosophila, trout, bovine, mouse, and human, abolished the interaction between pallidin and cytohesin-2. Taken together, it was suggested that the central region of pallidin corresponding to amino acids 31-157, especially the structural integrity of CC1, is important for the interaction of pallidin with cytohesin-2.
The cytohesin family comprises four homologous members (cytohesin-1, -2, -3, and -4), which share a conserved domain structure consisting of an N-terminal coiled coil domain, a central Sec7 domain, and a C-terminal PH domain. To examine the specificity of the interaction of pallidin with cytohesin-2, yeast was co-transformed with pallidin and each cytohesin member, and subjected to yeast two-hybrid assays. Yeast co-expressing pallidin and cytohesin-2 but not other cytohesins yielded high b-galactosidase activity and prototrophy for histidine and uracil (Fig. 2b) . In addition, a strong interaction was detected in yeast co-expressing FRMD4A and any cytohesin member (data not shown), suggesting a specific interaction of pallidin with cytohesin-2 among the cytohesin family.
To determine the region of cytohesin-2 required for the interaction with pallidin, truncated cytohesin-2 mutants consisting of the N-terminal 56-amino acids containing the coiled coil domain (cytohesin-2 [1-56]) or a central Sec7 domain and C-terminal PH domain (cytohesin-2 [58-400]) were co-expressed with full-length pallidin in yeast. The yeast co-expressing pallidin with cytohesin-2 (1-56) but not cytohesin-2 (58-400) showed high b-galactosidase activity and prototrophy for histidine and uracil (Fig. 2c) . To examine the possibility that the N-terminal region of cytohesin-2 is sufficient to confer the ability to interact with pallidin on other cytohesin members, we prepared a cytohesin-1 swap mutant (cytohesin-2N/1C), in which the N-terminal region of cytohesin-1 was replaced with that of cytohesin-2. Co-expression of cytohesin-2N/1C and pallidin in yeast revealed that swapping of the N-terminal region of cytohesin-1 with that of cytohesin-2 permitted cytohesin-1 to interact with pallidin ( Fig. 2c) , further suggesting the Pre-embedding silver-enhanced immunogold electron microscopy for cytohesin-2 in the stratum radiatum of the CA1 region, showing the localization of cytohesin-2 at the plasma membrane and intracellular membrane structures (arrows) in the dendritic shaft (o) and spines (p). (q) Quantification of the density of immunoreactive particles for cytohesin-2 in neuronal compartments. Note a higher density of cytohesin-2-immunoreactive particles in cell bodies, dendritic shafts, and spines. Data were obtained from a total 1024 lm 2 of the hippocampal CA1 area. Error bars represent SD. CA1 and CA3, hippocampal CA1 and CA3 regions of Ammon's horn; Cb, cerebellum; CPu, caudate putamen; Cx, cerebral cortex; DG, dentate gyrus; Dn, dendrite; ExT, excitatory presynaptic terminal; Hi, hippocampus; InT, inhibitory presynaptic terminal; MO, medulla oblongata; MVB, multivesicular body; OB, olfactory bulb; Or, stratum oriens; Py, pyramidal cell layer; Ra, stratum radiatum; Sp, dendritic spine; Th, thalamus. Scale bars, 1 mm (b and c); 100 lm (d and e); 10 lm (h, k, n); 200 nm (o and p).
requirement for the N-terminal region of cytohesin-2 for the specific interaction with pallidin.
To verify the interaction between cytohesin-2 and pallidin using an independent assay, HeLa cells were transfected with EGFP-cytohesin-1 or EGFP-cytohesin-2, and subjected to a pull-down assay with GST-pallidin (Fig. 2d) . GST-pallidin efficiently pulled down EGFP-cytohesin-2 but not EGFPcytohesin-1 from the HeLa cell lysates.
To examine the formation of a protein complex between cytohesin-2 and pallidin in vivo, HeLa cells were transfected with HA-pallidin and FLAG-cytohesin-1 or FLAG-cytohesin-2, and subjected to immunoprecipitation with an anti-HA antibody (Fig. 2e) . The anti-HA antibody efficiently immunoprecipitated FLAG-cytohesin-2 but not FLAG-cytohesin-1 with HA-pallidin from the lysates of transfected HeLa cells. Finally, we performed an immunoprecipitation assay using the brain lysate (Fig. 2g) . The anti-pallidin antibody, the specificity of which was confirmed by immunoblotting (Fig. 2f) , could immunoprecipitate endogenous cytohesin-2 from the mouse brain lysate (Fig. 2g) . In the reciprocal immunoprecipitation, the anti-cytohesin-2 antibody, however, could not immunoprecipitate detectable amounts of pallidin from the mouse brain (Fig. 2g) , suggesting that only a small fraction of cytohesin-2 may form a protein complex with pallidin in the brain.
Knockdown of pallidin perturbs the early endosomal pathway in hippocampal neurons
To examine whether cytohesin-2 and pallidin were colocalized in neurons, cultured hippocampal neurons were subjected to triple immunofluorescence staining with antibodies against cytohesin-2, pallidin, and EEA1 (Fig. 3a-j) . Both cytohesin-2 and pallidin were present as fine puncta in cell bodies and neurites, and partially colocalized in vesicular structures, some of which were labeled with EEA1 ( Fig. 3a-j) . Colocalization analysis (Table 4) revealed that the proportion of pallidin colocalized with cytohesin-2 to total pallidin (colocalization coefficient: 0.714 AE 0.209) was much higher than that of cytohesin-2 colocalized with pallidin (0.318 AE 0.209) to total cytohesin-2. In addition, the proportions of EEA1 colocalized with pallidin (0.409 AE 0.192) or cytohesin-2 (0.616 AE 0.248) to total EEA1 were much higher than those of pallidin or cytohesin-2 colocalized with EEA1 to total pallidin or cytohesin-2 (0.244 AE 0.032; 0.136 AE 0.029). These results indicated that a limited fraction of cytohesin-2 was associated with pallidin in EEA1-positive early endosomes.
The colocalization between pallidin and cytohesin-2 in EEA1-positive early endosomes prompted us to examine the effect of knockdown of pallidin or cytohesin-2 on the distribution of early endosomes in neurons. First, to check the efficiency of shRNAs for pallidin and cytohesin-2 in downregulating their target proteins, HeLa cells were co-transfected with FLAG-pallidin or EGFP-cytohesin-2, and shRNA for pallidin (shPallidin) or cytohesin-2 (shCytohesin-2), mismatched shRNAs (shControl) in which four nucleotides in the target sequences were mutated without changes in their overall nucleotide compositions, or shRNA for luciferase (shLuciferase). In a heterologous expression system, cotransfection of shPallidin or shCytohesin-2 significantly decreased the expression of FLAG-pallidin or EGFP-cytohesin-2, respectively, compared with that of shLuciferase (Fig. 3k, 4a ) or mismatched shRNAs (data not shown). Furthermore, cultured hippocampal neurons transfected with shRNAs for pallidin or cytohesin-2 exhibited significantly reduced immunolabeling for their respective targets by 43.3% and 60.3%, respectively, compared with those with mismatched shRNAs (Fig. 3l-p , Control: 1.000 AE 0.167, n = 25 neurons, shPallidin: 0.433 AE 0.259, n = 23, p = 0.0112, ttest; 4b-f, Control: 1.000 AE 0.161, n = 21, shCytohesin-2: 0.603 AE 0.136, n = 22, p = 0.00001, t-test), suggesting the efficiency of shRNAs. Of note, the knockdown of pallidin did not have apparent effects on the expression level and subcellular distribution of cytohesin-2, and vice versa (Fig. S2) .
Then, we examined the effect of pallidin knockdown on the distribution of EEA1-positive early endosomes in hippocampal neurons. Knockdown of pallidin significantly decreased the density of EEA1-positive puncta in cell bodies and dendrites of hippocampal neurons compared with its mismatched shRNA ( Fig. 3q-u ; cell body, Control: 19.3 AE 2.3, shPallidin: 10.0 AE 2.8, p = 0.0112, t-test; dendrite, Control: 17.7 AE 3.3, shPallidin: 7.4 AE 3.7, p = 0.0034, n = 22). To further examine whether knockdown of pallidin affected the endocytic pathway, neurons transfected with shPallidin or mismatched shControl were incubated with Alexa594-conjugated transferrin for 10 min, rinsed with an acid buffer to remove residual transferrin from the plasma membrane, and fixed. Knockdown of pallidin significantly decreased the cytoplasmic accumulation of transferrin compared with the control ( Fig. 3v-z ; Control: 1.000 AE 0.297, n = 24; shPallidin: 0.667 AE 0.173, n = 28, p = 0.0021, t-test). On the other hand, knockdown of pallidin did not have apparent effects on the density or distribution of LAMP2-positive late endosomes and lysosomes in the cell body (data not shown).
To examine whether knockdown of cytohesin-2 also had a similar effect on early endosomes, hippocampal neurons were transfected with shCytohesin-2 or mismatched shControl and subjected to immunofluorescence with anti-EEA1 IgG. Similarly, knockdown of cytohesin-2 significantly decreased the density of EEA1-positive puncta in neurons ( Fig. 4g-k , cell body, Control: 12.9 AE 2.8, shCytohesin-2: 8.0 AE 1.8, p = 0.0310, t-test; dendrite, Control: 12.3 AE 1.1, shCytohesin-2: 7.4 AE 3.7, p = 0.0035, Control: n = 23; shCytohesin-2: n = 22).
Developmental expression of pallidin in the hippocampus
To examine the developmental protein expression patterns of pallidin and cytohesin-2, we performed immunoblotting of hippocampi at various postnatal stages (Fig. 5) .
Quantification of the intensities of immunoreactive bands for pallidin and cytohesin-2 at various stages from three independent blots revealed that both pallidin and cytohesin-2 were transiently up-regulated with the peaks at P10 and P15, respectively, and thereafter decreased slightly to the adult levels.
Knockdown of pallidin promotes dendritic extension through the CC1 in cultured hippocampal neurons The developmental expression patterns of pallidin and cytohesin-2 were consistent with the most active period of dendritic formation in the hippocampus (Pokorny and Yamamoto 1981) . A previous study demonstrated that the neurite outgrowth of hippocampal neurons cultured from pallid mice was impaired at DIV3, the initial stage of neurite formation when neurites were still immature and just started to differentiate into axons and dendrites (Ghiani et al. 2010) . Therefore, we examined the roles of pallidin in the formation of axons and dendrites by silencing the expression of endogenous pallidin (Fig. 6) . Hippocampal neurons were transfected with shPallidin or shLuciferase at DIV2, fixed at DIV5, the stage when axons and dendrites were distinguishable by the immunoreactivity of tau and MAP2, respectively (data not shown). The overall morphology of axons and dendrites of shRNA-transfected neurons was visualized and examined by double immunofluorescence with antibodies against EGFP and MAP2 (Fig. 6) . Knockdown of pallidin significantly increased total dendritic length by 30% compared with shLuciferase ( Fig. 6a-f , m, shLuciferase: 1.000 AE 0.066, n = 54 neurons; shPallidin: 1.300 AE 0.036, n = 51; p = 0.0241, Fisher's PLSD) without any effects on the tip number of dendrites and axons, or total length of axons (Fig. 6n-p) . Sholl analysis failed to detect apparent changes in the dendritic complexity of transfected neurons between shPallidin and shLuciferase (Fig. S3 ). In the control experiment, co-expression of shRNA-resistant pallidin with shPallidin completely rescued the effect of pallidin knockdown on dendritic length (Fig. 6g-i , m, shPallidin plus pallidin: 1.104 AE 0.072, n = 62; p > 0.05) without any effects on other parameters (Fig. 6n-p) . The average actual values of the total length and tip number of dendrites and axons of the control neurons were 212.08 lm and 2.95 (dendrite) and 642.61 lm and 2.96 (axon), respectively, and individual values in each experimental condition were normalized to the control. Taking advantage of the inability of a pallidinDCC1 mutant to interact with cytohesin-2, hippocampal neurons were further co-transfected with shPallidin and shRNAresistant pallidinDCC1 mutant. Co-expression of pallidinDCC1 with shPallidin could not revert the increase in dendritic length caused by pallidin knockdown (Fig. 6j-m , shPallidin plus pallidinDCC1: 1.422 AE 0.140 n = 52; p = 0.0178, Fisher's PLSD) without affecting other parameters (Fig. 6n-p) .
Knockdown of cytohesin-2 inhibits dendritic extension in cultured hippocampal neurons
In previous studies using a catalytically inactive cytohesin-2 mutant, cytohesin-2 was reported to regulate the formation of axons and dendrites of cultured hippocampal neurons (Hernandez-Deviez et al. 2002 . We further examined the effects of cytohesin-2 knockdown on the formation of axons and dendrites in the present experimental conditions (Fig. 7) . Knockdown of cytohesin-2 significantly decreased total dendritic length (Fig. 7j , shLuciferase: 1.000 AE 0.059, n = 44 neurons; shCytohesin-2: 0.830 AE 0.069, n = 43; p = 0.0112, Fisher's PLSD) without any effects on other neurite parameters (Fig. 7k-m) . In the control experiment, co-expression of shRNA-resistant cytohesin-2 could revert the effect on total dendritic length caused by cytohesin-2 knockdown (Fig. 7j, 1 .067 AE 0.137, n = 52; p = 0.0009, Fisher's PLSD), suggesting the specificity of the effects of the shRNA.
Discussion
The cytohesin-Arf pathway has been implicated in various neuronal functions including neuronal survival and apoptosis (Hickman et al. 2018) , formation of axons and dendrites (Hernandez-Deviez et al. 2007) , presynaptic cycle of synaptic vesicles (Ashery et al. 1999) , and trafficking and surface expression of mGluRs (Kitano et al. 2002) . In the present study, we demonstrated the subcellular localization of cytohesin-2 in neurons at light and electron microscopic levels, and identified pallidin as a novel interacting protein with cytohesin-2 in neurons, which was confirmed by several independent assays including yeast two-hybrid, pulldown, immunoprecipitation, and immunostaining. Furthermore, we demonstrated the possible functional linkage between cytohesin-2 and pallidin in the early endosomal pathway and the dendritic formation in cultured hippocampal neurons. An increasing number of partner proteins for cytohesin have been identified and suggested to regulate the precise timing and location of activation of Arfs by recruiting cytohesin to specific subcellular compartments of the plasma membrane and organelles, and modulating the GEF activity (Table 1) . For example, Tamalin/GRP1-associated scaffold protein (GRASP) forms a complex with group I mGluR and cytohesin-2 at the postsynaptic membrane of excitatory synapses, thereby promoting the surface expression and trafficking of mGluRs (Kitano et al. 2002) . In differentiating N1E115 neuroblastoma cells, cytohesin-2 was shown to be recruited to the growth cone through an interaction with coiled coil domain-containing protein 120 (CCDC120) and actinin-1, thereby facilitating Arf6-dependent neurite extension (Torii et al. 2012 (Torii et al. , 2014 . However, because most of the partner proteins exhibit promiscuous affinity for more than one cytohesin member, it remains unclear how individual cytohesin members can exert specific functions. To the best of our knowledge, pallidin is the first identified partner protein specific for cytohesin-2 among the cytohesin family. The present two-hybrid assay with truncated and swap mutants of cytohesin-2 revealed that the N-terminal 56 amino acids containing a coiled coil domain is responsible for the specific interaction of cytohesin-2 with pallidin. The coiled coil domain of the cytohesin family is known to function as a module to mediate intramolecular interactions (Hiester and Santy 2013) , dimerization (Cherfils et al. 1998; Jun et al. 2016) , and interaction with several signaling and scaffold proteins including Gaq (Gigu ere et al. 2006; Laroche et al. 2007) , Tamalin/GRASP (Nevrivy et al. 2000; Kitano et al. 2002) , Cybr/CASP/CYTIP (Mansour et al. 2002; Tang et al. 2002; Boehm et al. 2003) , CNK1 (Lim et al. 2010) , CNK2 (Lim et al. 2014) , CNK3/IPCEF1 (Venkateswarlu 2003) , CCDC120 (Torii et al. 2014) , FRMD4A (Ikenouchi and Umeda 2010) , and FRMD4B (Ikenouchi and Umeda 2010) , most of which do not exhibit specificity in interacting with cytohesin-2. The amino acid identities of the N-terminal 56 amino acids of cytohesin-2 with cytohesin-1, -3, and -4 are 62%, 48%, and 30%, respectively. A further structural analysis is needed to understand the mechanism for the specific interaction between cytohesin-2 and pallidin.
The present immunoelectron microscopic analysis revealed that cytohesin-2 was associated with the plasma membrane and membrane vesicles corresponding to endosomes and multivesicular bodies in various subcellular compartments, particularly the somatodendritic compartment, which is consistent with the idea that the subcellular localization of cytohesin depends on the interaction with various partners. For example, cytohesin-2 localized at the lateral margin of the postsynaptic density in the dendritic spine ( Fig. 1p) , which was consistent with the previous finding that cytohesin-2 forms a protein complex with group I mGluRs through an interaction with tamalin (Kitano et al. 2002) . Double immunofluorescence of hippocampal neurons demonstrated that cytohesin-2 partially colocalized with syntaxin 12 (Fig. 1i-k) , which may reflect the interaction of cytohesin-2 with pallidin, because pallidin was previously shown to interact with syntaxin 12 (Huang et al. 1999 ). The present triple immunofluorescence also demonstrated the colocalization of cytohesin-2 and pallidin in EEA1-positive early endosome. On the other hand, Larimore et al. (2013) demonstrated that pallidin immunoreactivity was present in the cell bodies, axon terminal, dendritic shaft, and spines in the mouse dentate gyrus. At an ultrastructural level, the immunolabeling of pallidin was associated with synaptic vesicles in the presynaptic terminal, and coated vesicles, cisternae, and multivesicular bodies in the dendritic spine (Larimore et al. 2013) , suggesting the association of pallidin with various membrane structures. This result was consistent with the present immunofluorescent findings of the punctate appearance of pallidin and its partial colocalization with EEA1. Therefore, it is plausible that pallidin may specifically recruit cytohesin-2 to various subsets of endosomes, where cytohesin-2 can exert isoform-specific neuronal functions through Arf-dependent endosomal trafficking and/or actin cytoskeleton remodeling. The colocalization of a subpopulation of cytohesin-2 and pallidin in EEA1-positive early endosomes prompted us to examine the functional roles of pallidin and cytohesin-2 in early endosomes. Knockdown of pallidin reduced the cytoplasmic distribution of EEA1-positive early endosomes and cytoplasmic accumulation of transferrin in cultured hippocampal neurons. Because knockdown of pallidin did not have apparent effects on the distribution of late endosomes and lysosomes in pallidin-knockdown neurons, it is reasonable to conclude that the phenotypes caused by pallidin knockdown are ascribed to disturbance in the endocytic pathway to early endosomes rather than that in other pathways such as the recycling or degradation pathways. Similarly, knockdown of cytohesin-2 reduced cytoplasmic EEA1 puncta. Therefore, it is likely that pallidin and cytohesin-2 may cooperatively regulate the endocytic pathway to early endosomes in hippocampal neurons. However, HernandezDeviez et al. previously showed that the expression of a catalytically inactive mutant of cytohesin-2 redistributed endotubulin, an integral membrane protein in early endosomes, from the cytoplasm to the plasma membrane along the axon without affecting the distribution of EEA1 in the cell body of cultured hippocampal neurons (Hernandez-Deviez et al. 2007) , which is inconsistent with the present findings on the effect of cytohesin-2 knockdown on the distribution of EEA1. Whether this discrepancy may reflect differences in experimental conditions such as loss-of-function analyses with catalytically inactive mutant versus shRNA remains unclear at present. In addition, we cannot rule out the possibility that subtle disturbances in other pathways by knockdown of pallidin and cytohesin-2 may affect the whole intracellular vesicular transport system, eventually leading to inhibition of endocytosis and the redistribution of early endosomes. Indeed, endocytosis of transferrin, Tyrp1, and LAMP-1 was shown to be disturbed in BLOC-1-deficient immortal melanocytes generated from mice lacking muted due to the secondary consequence of impaired trafficking and sorting in early endosomes (Setty et al. 2007) . Therefore, further analyses are necessary to understand the functional role of the interaction between cytohesin-2 and pallidin in the endosomal transport system in neurons.
The present immunoblotting analyses demonstrated the developmental expression patterns of pallidin and cytohesin-2 in the hippocampus with peaks at P10 and P15, respectively, which parallels well with the most active period of dendritic formation in the hippocampal formation (Pokorny and Yamamoto 1981) . Indeed, hippocampal neurons derived from pallid mutant mice showed impaired initial outgrowth and extension of neurites at DIV3, when neurites were still immature and just starting to differentiate into axon and dendrites. In this study, knockdown of pallidin significantly increased total dendritic length in cultured hippocampal upper (a, d, g, j) and middle panels (b, e, h, k) is magnified in the lower panels (c, f, i, l). Arrowheads indicate axons, which were defined by a single long thin process devoid of MAP2 immunolabeling. (m-p) Quantification of total dendritic length (m), dendritic tip number (n), total axonal length (o), and axonal tip number (p). Note enhanced dendritic elongation by pallidin knockdown, which could be rescued by co-expression of wild-type pallidin but not pallidinDCC1. Control, n = 54 neurons; Pallidin KD, n = 51 neurons; Pallidin KD + WT, n = 62 neurons; Pallidin KD + DCC1, n = 52 neurons. Error bars represent SEM. Data are shown as the ratio normalized to mean values for control neurons and statistically evaluated using oneway ANOVA with Fisher's protected least significant difference (PLSD) test for multiple comparisons (* p < 0.05). Scale bars, 100 lm (j, k, l). neurons without affecting dendritic branching, and axonal length and branching. Furthermore, the dendritic phenotype caused by pallidin knockdown was rescued completely by co-expression of wild-type pallidin, but not with a pallidinDCC1 mutant lacking the ability to interact with cytohesin-2. These results suggested that the suppression of dendritic extension by pallidin may be mediated by the interaction of CC1 with cytohesin-2 or other unidentified partners. Paradoxically, knockdown of cytohesin-2 significantly decreased total dendritic length in the same experimental conditions. Several possibilities could be explained for this discrepancy of the phenotypes between pallidin and cytohesin-2 knockdown, assuming that the complex between pallidin and cytohesin-2 functions in the dendritic formation. First, the present quantitative colocalization analysis revealed that the proportion of pallidin colocalized with cytohesin-2 was much higher than that of cytohesin-2 colocalized with pallidin, indicating that only a limited fraction of cytohesin-2 is associated with pallidin in vivo. Therefore, even if cytohesin-2 and pallidin actually function together in a limited subcellular compartment, global knockdown of cytohesin-2 in neurons may have different effects on the neurite phenotype from knockdown of pallidin or blocking the functional interaction between cytohesin-2 and pallidin by pallidinDCC1. Second, it is also possible to speculate that pallidin may negatively regulate the stimulatory effect of the cytohesin-2-Arf pathway on dendritic formation through the interaction. The roles of the cytohesin-2-Arf6 pathway in the neurite formation are still controversy. Hernandez-Deviez et al. (2002 showed that over-expression of catalytically inactive mutants of cytohesin-2 or Arf6 increased the length and branching of axons and dendrites in cultured hippocampal neurons. However, the loss-of-function phenotypes with these mutants should be interpreted with caution, because expression of either catalytically active or inactive mutants of Arf6 and its regulatory proteins can disturb the proper functioning of the GTP/GDP cycling of Arf6, eventually leading to the same loss-of-function phenotype.
For example, we recently demonstrated that expression of catalytically active or inactive Arf6 mutants in neuroblasts similarly disturbed neuronal migration of cortical progenitor cells during the cerebral cortical layer formation (Hara et al., 2016) . Miura et al. (2016) demonstrated that total neurite length, but not total neurite number, was significantly decreased in cultured hippocampal neurons transfected with shRNA for Arf6 or prepared from Arf6 knockout mice. Therefore, the opposite effects of knockdown between pallidin and cytohesin-2 on total dendritic length can lead to the speculation that the interaction of pallidin with cytohesin-2 may negatively regulate the stimulatory effect of the cytohesin-2-Arf pathway on dendritic extension by suppressing the GEF activity of cytohesin-2 toward Arf6.
These possibilities need to be tested in future studies.
Finally, accumulating evidence suggests a functional relationship between the Arf pathway and BLOC-1. Based on the similarity of the phenotypes related to HermanskyPudlak syndrome between mice deficient in BLOC-1 components and those deficient in adaptor protein complex 3 (AP-3), BLOC-1 was found to form a protein complex with AP-3 to coordinately function in membrane trafficking destined for lysosomes and lysosome-related organelles (Di Pietro et al. 2006) . AP-3 is recruited to the membrane through the interaction with GTP-bound Arf1 (Ooi et al. 1998) and AGAP1, an Arf1-GAP also known as centaurinc2 (Nie et al. 2003) . In neurons, AGAP1 regulates the recycling of muscarinic acetylcholine receptors in association with AP-3 and BLOC-1 (Bendor et al. 2010) , suggesting a physical and functional association between BLOC-1 and AGAP1 via AP-3. Therefore, it is tempting to hypothesize that BLOC-1 may serve to bridge opposing regulatory proteins for Arf1, Arf-GEF (cytohesin-2) via pallidin, and Arf-GAP (AGAP1) via AP-3, in the same protein complex, thereby fine-tuning the GTP/GDP cycling of Arf1 on endosomes in neurons. Recent evidence implicates a disturbance in the endosomal trafficking pathway in the pathogenesis of neurodevelopmental disorders including schizophrenia, autism spectrum disorders, and intellectual disability. Of note, dysbindin, neuronal-specific AP-3 subunit, and AGAP1 were identified as risk factors for schizophrenia and autism spectrum disorder (Straub et al. 2002; Wassink et al. 2005; Sebat et al. 2007; O'Roak et al. 2012) . In schizophrenia patients, dysbindin was reduced in the synaptic field of the hippocampus compared with the levels in matched controls (Talbot et al. 2004) . Mice deficient in either dysbindin (sandy) or pallidin (pallid) showed various behavioral phenotypes such as impaired (a, d, g, magenta) and MAP2 (b, e, h, green) in cultured hippocampal neurons transfected with shLuciferase (Control, a-c), shCytohesin-2 (Cytohesin-2 KD, d-f), and shCytohesin-2 plus shRNA-resistant wild-type cytohesin-2 (Cytohesin-2 KD + Cytohesin-2 WT, g-i). The morphology of the dendrites, which were double-labeled in yellow for mCherry and MAP2, in transfected neurons shown by arrows in the upper (a, d, g ) and middle panels (b, e, h) is magnified in the lower panels (c, f, i). Arrowheads indicate axons, which were defined by a single long thin process devoid of MAP2 immunolabeling. (j-m) Quantification of total dendritic length (j), dendritic tip number (k), total axonal length (l), and axonal tip number (m). Note decreased total dendritic length by cytohesin-2 knockdown, which could be rescued by co-expression of wild-type cytohesin-2. Control, n = 44 neurons; Cytohesin-2 KD, n = 43 neurons; Cytohesin-2 KD + WT, n = 52 neurons. Error bars represent SEM. Data are shown as the ratio normalized to mean values for control neurons and statistically evaluated using one-way ANOVA with Fisher's PLSD test for multiple comparisons (*p < 0.05). Scale bars, 100 lm (g, h, i).
working memory and social interactions, which are consistent with the neurobehavioral phenotypes of animal models of schizophrenia (Takao et al. 2008; Bhardwaj et al. 2009; Cox et al. 2009; Jentsch et al. 2009; Karlsgodt et al. 2011; Glen et al. 2014; Spiegel et al. 2015) . Therefore, it would be interesting to test the possibility that disturbance in the crosstalk between the cytohesin-2-Arf pathway and BLOC-1 in endosomal trafficking may contribute to the pathogenesis of neurodevelopmental disorders. manuscript: MF, HS. Administrative, technical, and material support: TS, YH, JY, HO, HS. The authors declare no conflict of interest.
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